The Use of Carbamazepine in Patients with Manic Depressive Illness
نویسندگان
چکیده
16 cases of affective disorder were studied. 8 patients received carbamazepine and 8 received either chlorpromazine or imipramine. Ratings were carried out on the Hamilton Rating Scale for Depression, Bech Rafaelsen Mania Rating scale and a side-effects symptom check list. Garbamazepine was found to be an effective treatment for affective disorders, possessing both anti-manic as well as anti-depressant properties.
منابع مشابه
Lithium compared to valproic acid and carbamazepine in the treatment of mania: a statistical meta-analysis.
The hypothesis that lithium is the most appropriate and efficacious pharmacological treatment in the therapy of manic-depressive illness was examined in a meta-analysis. The efficacy of lithium was compared with that of the antiepileptics, carbamazepine and valproic acid. Data sources include the Medline database and relevant references from articles. Only randomised controlled clinical trials ...
متن کاملBipolar disorder and tuberous sclerosis complex: is it a mere coincidence?
Tuberous sclerosis complex (TSC) is associated with significant psychiatric comorbidity mainly in the form of autistic disorders, hyperkinetic disorders, depression, and anxiety disorders. There are very few reports of bipolar disorder in TSC. The authors present the case of a patient with TSC having bipolar disorder manifesting as manic as well as depressive episodes. The diagnosis of TSC was ...
متن کاملCarbamazepine overdose after exposure to simethicone: a case report
INTRODUCTION Carbamazepine is an anticonvulsant drug and is also used as a treatment for patients with manic-depressive illness, post-herpetic neuralgia or phantom limb pain. The drug itself has many drug interactions. Simethicone is an antifoaming agent and is reported to be an inert material with no known drug interaction with carbamazepine. CASE PRESENTATION We present a case of a patient ...
متن کاملLong-term Treatment of Bipolar Disorder with Carbamazepine Extended-Release Capsules in Adults, Adolescents, and Children
Bipolar disorder is a serious, lifelong illness that affects approximately 5.7 million American adults, or approximately 2.6% of the US population 18 years of age and over in a given year. The median age of onset is 25 years. It is a complex illness characterized by mania, depression, or mixed episodes, and rapid cycling. Diagnosis and treatment are often complicated by the presence of a variet...
متن کاملمقایسه اثر لیتیوم،کاربامازپین و والپروئات در درمان مرحله حاد مانیای کلاسیک
The purpose of this study was to compare the effectiveness of three common mood stabilizing drugs, Lithium, Carbamazepine and Valproate in the treatment of acute mania Of the 114 patients who participated in this study, 60 were treated with Lithium, 30 with Carbamazepine and 24 with Valproate. This study was a prospective and double blind study. The patients were assessed by GAF Scale and a man...
متن کامل